PDGFR-β+ fibroblasts deteriorate survival in human solid tumors: a meta-analysis
Figure 2. Subgroup analyses describing HRs of the association between PDGFR-β+ fibroblast infiltration and OS in breast cancer (A), NSCLC (B), Hepatic carcinoma (C), and pancreatic cancer (D). HRs: hazard ratios; OS: overall survival.